20.09.2019: Recent publication on the downregulation of miR-146a
We as Nanion Technologies would like to congratulate Li Shen and the co-authors of this insightful paper. The paper shows that sunitinib downregulates miR-146a, thereby contributing to cardiac contractile dysfunction by targeting PLN and ANK2. miR-146a could thus, be a useful protective agent against sunitinib-induced cardiac dysfunction. We are honoured that the group from the Pharmacology department of the Hebei Medical University, China used among other assays, the Cardioexcyte 96 for this study.